Abdala-Vargas Nadin J, Umana Giuseppe E, Patiño-Gomez Javier G, Ordoñez-Rubiano Edgar, Cifuentes-Lobelo Hernando A, Palmisciano Paolo, Ferini Gianluca, Viola Anna, Zagardo Valentina, Casanova-Martínez Daniel, Tomasi Ottavio S, Campero Alvaro, Baldoncini Matias
Neurosurgery Department, Fundación Universitaria de Ciencias de la Salud (FUCS), Hospital Infantil Universitario de San José, Cra. 19 #8A-32, Bogotá 111221, Colombia.
Department of Neurosurgery, Trauma and Gamma-Knife Center Cannizzaro Hospital, 95126 Catania, Italy.
Brain Sci. 2023 Mar 15;13(3):498. doi: 10.3390/brainsci13030498.
The aim of this work is to define a methodological strategy for the minimally invasive tubular retractor (MITR) parafascicular transulcal approach (PTA) for the management of brain tumors sited in eloquent areas.
An observational prospective study was designed to evaluate the benefits of PTA associated with MITRs, tractography and intraoperative cortical stimulation. They study was conducted from June 2018 to June 2021. Information regarding white matter tracts was processed, preventing a potential damage during the approach and/or resection. All patients older than 18 years who had a single brain tumor lesion were included in the study. Patients with a preoperative Karnofsky Performance Scale (KPS) score greater than 70% and a Glasgow Coma Scale (GCS) score > 14 points were included.
72 patients were included in the study, the mean age was 49.6, the most affected gender was male, 12.5% presented aphasia, 11.1% presented paraphasia, 41.6% had motor deficit, 9.7% had an affection in the optic pathway, the most frequently affected region was the frontal lobe (26.3%), the most frequent lesions were high-grade gliomas (34.7%) and the measurement of the incisions was on average 5.58 cm. Of the patients, 94.4% underwent a total macroscopic resection and 90.2% did not present new postoperative neurological deficits. In all cases, a PTA was used.
Tubular minimally invasive approaches (MIAs) allow one to perform maximal safe resection of brain tumors in eloquent areas, through small surgical corridors. Future comparative studies between traditional and minimally invasive techniques are required to further investigate the potential of these surgical nuances.
本研究旨在确定一种用于治疗位于功能区的脑肿瘤的微创管状牵开器(MITR)束旁经沟入路(PTA)的方法策略。
设计一项观察性前瞻性研究,以评估PTA联合MITR、神经束成像和术中皮层刺激的益处。该研究于2018年6月至2021年6月进行。处理有关白质束的信息,以防止在入路和/或切除过程中造成潜在损伤。所有年龄大于18岁且患有单个脑肿瘤病变的患者均纳入本研究。纳入术前卡氏功能状态评分(KPS)大于70%且格拉斯哥昏迷量表(GCS)评分>14分的患者。
72例患者纳入本研究,平均年龄49.6岁,男性受累最多,12.5%出现失语,11.1%出现错语症,41.6%有运动功能障碍,9.7%视神经通路受累,最常受累区域为额叶(26.3%),最常见病变为高级别胶质瘤(34.7%),切口平均长度为5.58 cm。94.4%的患者进行了肉眼全切,90.2%的患者术后未出现新的神经功能缺损。所有病例均采用PTA。
管状微创入路(MIA)可通过小手术通道在功能区对脑肿瘤进行最大程度的安全切除。未来需要对传统技术和微创技术进行比较研究,以进一步探究这些手术细微差别的潜力。